Latest Form 4 insider transactions

Rikki Powell, Chief Financial Officer of Shutterstock, Inc., received 65,502 shares of common stock on August 7, 2026.

Michelangelo Volpi, a Director of Aurora Innovation, Inc., sold 1,889,023 shares of common stock on August 7, 2026.

Holger Weis, CEO of Alaunos Therapeutics, Inc., received 4,363 shares of common stock on August 6, 2026.

Katherine A Maher, CVP and CAO of Motorola Solutions, Inc., sold 1,754 shares of common stock on August 7, 2026.

Trevor Montano, a Director of Eagle Bancorp Inc, reported multiple transactions in common stock on May 30, 2026.

Claire Herkes, EVP, Conferences of Gartner Inc, sold 1,039 shares of common stock on August 7, 2026 for $190.71 per share.

Pendeven Yves Le, CFO of Funko, Inc., sold 14,255 shares of common stock on August 7, 2026.

Lisa Ann Davis, a Director of Phillips 66, sold 1,515 shares of common stock on August 10, 2026.

Christopher Swift, Chairman and CEO and a Director of Hartford Financial Services Group, Inc., reported a transaction in 35,088 shares of common stock on August 7, 2026.

Robert James Blair, SVP, General Counsel of Viasat Inc, sold 27,064 shares of common stock on August 7, 2026 for $79.76 per share.

Raj Khanna, a Director of Extreme Networks Inc, sold 15,000 shares of common stock on August 10, 2026 for $24.20 per share.

Scot Greulach, Chief Accounting Officer of Stanley Black & Decker, Inc., sold 1,015 shares of common stock on August 7, 2026 for $103.61 per share.

Ann M Kluppel, SVP and Controller of Phillips 66, sold 7,834 shares of common stock on August 7, 2026.

David R Bickerton, a Director of Consumers Bancorp Inc /Oh/, purchased 200 shares of common stock on August 11, 2026.

Silver Point Capital L.P. and 2 others reported changes in beneficial ownership of STUDIO CITY INTERNATIONAL HOLDINGS Ltd common stock on August 7, 2026.

Sanara MedTech announced a 9% revenue increase to $28.1 million for Q2 2026, alongside a pending acquisition by MiMedx.

Richard Scott Struthers, President & CEO and a Director of Crinetics Pharmaceuticals, Inc., reported multiple transactions in common stock on August 7, 2026.

Gweltaz Toquet, Chief Commercial Officer of Ceva Inc, received 30,293 shares of common stock on August 7, 2026.

Ravi Simhambhatla, EVP, CDIO - see remarks of Avis Budget Group, Inc., sold 4,702 shares of common stock on August 7, 2026.

Kenneth Stillwell, COO, CFO of Pegasystems Inc, reported multiple transactions in common stock on August 10, 2026.

Amir Panush, Chief Executive Officer and a Director of Ceva Inc, received 60,587 shares of common stock on August 7, 2026.

Yaniv Arieli, Chief Financial Officer of Ceva Inc, received 30,293 shares of common stock on August 7, 2026.

Daniel A. Hudson, EVP, CLO & Corporate Secretary of Tidewater Inc, sold 5,000 shares of common stock on August 10, 2026 for $89.01 per share.

Michael Robert Foley, See Remarks of Chemours Co, purchased 1,934 shares of common stock on August 7, 2026 for $15.51 per share.

Alister Cowan, a Director of Chemours Co, purchased 13,000 shares of common stock on August 7, 2026 for $15.62 per share.

Mary B Cranston, a Director of Chemours Co, purchased 6,000 shares of common stock on August 7, 2026 for $15.82 per share.

Joseph T. Martinko, See Remarks of Chemours Co, purchased 1,940 shares of common stock on August 7, 2026 for $15.47 per share.

Patrick H. Hawkins, CEO AND PRESIDENT and a Director of Hawkins Inc, reported a transaction in 580 shares of common stock on August 7, 2026.

Cornelius P. Mccarthy Iii, a Director of Medpace Holdings, Inc., sold 795 shares of common stock on August 7, 2026 for $585.07 per share.

Sarah Piper, Chief Human Relations Officer of Mccormick & Co Inc, received 48 shares of common stock on August 10, 2026.